Call：+86 13413644741 
E-mail：market@ca-marketresearch.com Building on the huge success of monoclonal antibody therapeutics, the next generation of antibody-based products such as Antibody Drug Conjugate (ADC) and Bispecific Antibody (BsAb) is now opening up new opportunities.
This report aims to provide a comprehensive presentation of the global market for Next Generation Antibody Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next Generation Antibody Therapeutics. This report contains market size and forecasts of Next Generation Antibody Therapeutics in global, including the following market information:
Global Next Generation Antibody Therapeutics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Next Generation Antibody Therapeutics market was valued at US$ 9878.9 million in 2022 and is projected to reach US$ 36620 million by 2029, at a CAGR of 20.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global key players of next generation antibody therapeutics include Roche, Seagen, Amgen, Pfizer, Takeda, etc. The top two players hold a share over 70%. North America is the largest market, has a share about 65%, followed by Europe and Asia-Pacific, with share 16% and 15%, separately. In terms of product type, Antibody Drug Conjugate (ADC) is the largest segment, occupied for a share of 60%, and in terms of application, Cancer has a share about 66 percent.
CA MARKET RESEARCH CO.,LTD (CAR) has surveyed the Next Generation Antibody Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Next Generation Antibody Therapeutics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Next Generation Antibody Therapeutics Market Segment Percentages, by Type, 2022 (%)
Antibody Drug Conjugate (ADC)
Bispecific Antibody (BsAb)
Global Next Generation Antibody Therapeutics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Next Generation Antibody Therapeutics Market Segment Percentages, by Application, 2022 (%)
Cancer
Haemophilia
Other Non-Cancer Diseases
Global Next Generation Antibody Therapeutics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Next Generation Antibody Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Next Generation Antibody Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Next Generation Antibody Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Amgen
Pfizer
Takeda
Daiichi Sankyo
Seagen
Astellas
Immunomedics
GSK
Immunocore
ADC Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Next Generation Antibody Therapeutics, market overview.
Chapter 2: Global Next Generation Antibody Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Next Generation Antibody Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Next Generation Antibody Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
Copyright © 2012-2021 版权所有
备案号粤ICP备2021079044号
